2020

Reducing Risk of MI and Stroke in Patients With Established CVD: Role of PCSK9 Inhibitors – CME Program NEW

Dyslipidemia, Diabetes, And Cardiovascular Risk: Clinical Strategies and Evolving Treatments – CME program NEW

Primary CV Risk Reduction Strategies – CME Program

T2D Management: Focus on CV Event Prevention – CME Program

2019

Diabetes from the Perspective of the Cardiologist: An Evolving Paradigm – CME Program

Shared-Decision Making in Dyslipidemia: What Do the Latest Cholesterol Guidelines Suggest? – CME Program

2018

Addressing Access to PCSK9 Inhibitors: Tips and Tools for Practicing Clinicians – CME Program

Congress Evaluation

2019 Program Evaluation & Credit Claim Forms

2019 Preconference Course (July 18-19, 2019) – Preventive Cardiology Expert’s Course
2019 Congress on CVD Prevention (July 19-21, 2019)